s 16020-2 has been researched along with daunorubicin in 2 studies
| Studies (s 16020-2) | Trials (s 16020-2) | Recent Studies (post-2010) (s 16020-2) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
|---|---|---|---|---|---|
| 20 | 2 | 1 | 8,239 | 886 | 1,310 |
| Protein | Taxonomy | s 16020-2 (IC50) | daunorubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvord, WG; Gray-Goodrich, M; Jeffers, M; Kohlhagen, G; Koo, HM; McWilliams, MJ; Monks, A; Paull, KD; Pommier, Y; Vaigro-Wolff, A; Vande Woude, GF | 1 |
| Koo, HM; Vande Woude, GF | 1 |
2 other study(ies) available for s 16020-2 and daunorubicin
| Article | Year |
|---|---|
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Carbazoles; Colonic Neoplasms; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, ras; Humans; Mutation; Phenotype; Pyridines; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured | 1999 |
Re: The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Carbazoles; Daunorubicin; Enzyme Inhibitors; Genes, ras; Humans; Neoplasms; Pyridines; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1999 |